Vaisiaus poveikio alkoholiu paplitimo ir alkoholio įtakos naujagimių medžiagų apykaitai tyrimas Lietuvoje (ALKOMET) (2017-2018).

Deciphering the genetic architecture of intellectual disability and congenital anomalies (INGENES) (2017-2020).

Funkcinis mitochondrinių ligų įvertinimo ir biožymenų nustatymo modelis (2015-2017).

Unique genome variants in congenital neurodevelopmental disorders: origin, genomic mechanisms, functional and clinical consequences (UNIGENE) (2012-2016).

Genetic diversity of the population of Lithuania and changes of its genetic structure associated with evolution and common diseases (LITGEN) (2011-2015).

Genomic diversity of the Lithuanian population and the possibility for the personalized treatment of coronary heart disease (LIGENKOR) (2010-2011). National Scientific Programme Chronic Noninfection Diseases approved by Research Council of Lithuania.

Evaluation of Pathogenic Copy Number Variation in Etiopathology of Mental Retardation (PROGENET) (2010-2011). National Scientific Programme Chronic Noninfection Diseases approved by Research Council of Lithuania.


Mechanisms of the disease pathogenesis determined by the varaity of human genome (2007–2009).

Investigation of genetic and genomic basis of cleft lip and/or cleft palate (GENOLOG) (2007-2009).

Development of diagnostics, treatment and prevention of rare inherited diseases in Lithuania (RETAGEN) (2006).

Human genome diversity, its origin and phenotypic realization (2005–2007).

Genomics in propxylaxis and treatment of children diseases (2004–2006).

Human genome diversity determined pathogenetic mechanisms of atherosclerosis (ATHEROGEN) (2004–2006).

Investigation of 10 DNA markers in five genes related to cleft lip/palate (2004).

Molecular genetic testing in phenylketonuria: a model to assess the quality control system for monogenic disease (2000–2002).

The structure, defects and protection of gene pool of the Lithuanian population (1997–2004).

Clinical and molecular genetic investigation of inherited photoreceptor diseases (1997–1999).

Estimation of the efficiency of the prenatal diagnosis system (1996–1998).

Molecular genetic investigation of inherited retinal pathology (1996).

Identification of nonsense mutations in APC gene in patients with familial adenomatous polyposis (1996).

Molecular genetic investigation of congenital blindness due to a retinal pathology (1995).

Lithuanian programme of perinatology, neonatology and prevention of congenital anomalies (1992–1996).

Human genome variety, diagnosis of foetal condition, perinatological conditions, features of child organism in norm and pathology (1992–1996).

†Unique genome variants in congenital neurodevelopmental disorders: origin, genomic mechanisms, functional and clinical consequences - UNIGENE (2012-2016).

†Improving Diagnoses of Mental Retardation in Children in Central Eastern Europe and Central Asia through Genetic Characterisation and Bioinformatics/Statistics – CHERISH (2009-2012).

†ECORN-CF: European Centres of Reference Network for Cystic Fibrosis) (2007–2009).

†EUROGENE: the first pan-European learning service in the field of genetics) (2007–2009).

†Taiwan-Baltic Programme of Mutual Funds: joint research project “Identification of genes involved in craniofacial morphogenesis and susceptibility to orofacial clefting in a human genome scan” (2003–2005). Scientific coordinator – prof. V. Kučinskas.

†EC FP5 GROWTH programme project “Quality in molecular genetic testing: development of certified reference materials” (CRMGEN; Contract No: G6RD-CT-2001-00581) (2002–2005).

†EC project “Network of Public Health Institutions on Rare Diseases“ (NEPHIRD) (2001–2002).

†EC 4FP INCO-COPERNICUS programme: joint research project “Molecular genetic testing in phenylketonuria: a model to assess the quality control system for monogenic disease” (MOLGENT; contract No ERB IC15-CT98-0337) (1999–2002).

†EC FP4 INCO-COPERNICUS programme: multicenter project “Genotype-Phenotype Correlation in MEN1 and HNPCC” (1998–2001, Contract No. IC15-CT98-0305) (1998–2000).

†EC FP4 Concerted Action of the European Communities “Prevention of Blindness: Molecular and Clinical Research in Photoreceptor Disorders” (Contract No. ERBCIPDCT 930124) (1997–1999).

†EC FP4 BIOMED-2 programme: Concerted Action of the European Communities “Evaluation of Prenatal Diagnosis of Congenital Anomalies by Fetal Ultrasonographic Examination” (EUROSCAN) (1996–1998).

†EUROFAP EC Concerted Action: Genetic Studies in Cancer Families; project No. ERBCIPDCT 940202 (1996).

†Concerted Action on Genetic Services in Europe (1995–1997).

†EC Concerted Action: Automation Molecular Cytogenetics Analyses (PECO-CA-AMCA; Contract No. BMH1-CT92-130) (1994–1996).


†EC Concerted Action “Prevention of Blindness: Molecular Research and Medical Care in Retinitis Pigmentosa (RP)” (Contract No. ERB BMH1CT921789) (1994–1996).


†Baltic population genetics collaborative programme (partners: Sweden, Finland, Latvia, Estonia, and Lithuania) (1992–2004).

† - international projects